• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-乙酰半胱氨酸治疗抵抗性精神分裂症的有益作用。

Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia.

机构信息

Department of Psychiatry, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.

出版信息

World J Biol Psychiatry. 2009;10(4 Pt 2):626-8. doi: 10.1080/15622970903144004.

DOI:10.1080/15622970903144004
PMID:19735056
Abstract

Poor response to antipsychotics is still an important problem in the treatment of many schizophrenia patients. N-acetylcysteine (NAC) is a compound that exerts anti-oxidant and scavenging actions against reactive oxygen species. This paper reports a case of poorly responsive schizophrenia patient who improved considerably with add-on NAC 600 mg/day. The NAC might work through activating cysteine-glutamate antiporters or reducing in nitric oxide (NO) metabolites, free radicals and cytokines or through both of these mechanisms.

摘要

抗精神病药物治疗反应不佳仍然是许多精神分裂症患者治疗中的一个重要问题。N-乙酰半胱氨酸(NAC)是一种具有抗氧化和清除活性氧作用的化合物。本文报告了一例对治疗反应不佳的精神分裂症患者,加用 NAC 600mg/天后病情明显改善。NAC 可能通过激活半胱氨酸-谷氨酸转运体或减少一氧化氮(NO)代谢物、自由基和细胞因子,或者通过这两种机制发挥作用。

相似文献

1
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia.N-乙酰半胱氨酸治疗抵抗性精神分裂症的有益作用。
World J Biol Psychiatry. 2009;10(4 Pt 2):626-8. doi: 10.1080/15622970903144004.
2
Placebo-controlled augmentation trials of the antioxidant NAC in schizophrenia: A review.精神分裂症中抗氧化剂N-乙酰半胱氨酸(NAC)的安慰剂对照增效试验综述
Ann Clin Psychiatry. 2016 Aug;28(3):190-6.
3
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial.N-乙酰半胱氨酸(NAC)辅助治疗慢性精神分裂症症状的疗效:一项双盲、随机临床试验。
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:289-296. doi: 10.1016/j.pnpbp.2017.11.001. Epub 2017 Nov 7.
4
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.氯氮平耐药的精神分裂症患者使用N-乙酰半胱氨酸(NAC):一项针对阴性症状的双盲随机安慰剂对照试验
BMC Psychiatry. 2016 Sep 15;16(1):320. doi: 10.1186/s12888-016-1030-3.
5
Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophrenia.抗精神病药-米诺环素-乙酰半胱氨酸联合治疗精神分裂症的阳性、认知和阴性症状。
Asian J Psychiatr. 2019 Feb;40:100-102. doi: 10.1016/j.ajp.2019.02.007. Epub 2019 Feb 12.
6
A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.氯哌噻吨癸酸酯与氟奋乃静癸酸酯治疗慢性精神分裂症门诊患者的双盲对照试验。
Pharmatherapeutica. 1983;3(5):289-93.
7
Long-term treatment of chronic schizophrenics with clopenthixol decanoate.用癸酸氯哌噻吨对慢性精神分裂症患者进行长期治疗。
Pharmatherapeutica. 1984;4(1):53-6.
8
An open study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses.醋酸珠氯噻醇在急性精神病患者中以维斯科利奥剂型进行的开放性研究。
Schizophr Res. 1988 Sep-Oct;1(5):359-61. doi: 10.1016/0920-9964(88)90049-7.
9
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia.早期药物试验中的定性方法:从精神分裂症中 N-乙酰半胱氨酸的 RCT 拓宽数据和方法的范围。
J Clin Psychiatry. 2011 Jul;72(7):909-13. doi: 10.4088/JCP.09m05741yel. Epub 2010 Sep 21.
10
N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.N-乙酰半胱氨酸作为利培酮治疗自闭症易怒症状的辅助疗法:一项关于疗效和安全性的随机、双盲、安慰剂对照临床试验
Clin Neuropharmacol. 2015 Jan-Feb;38(1):11-7. doi: 10.1097/WNF.0000000000000063.

引用本文的文献

1
The protective effect of N-acetylcysteine against MK-801-induced neurodegeneration in mice.N-乙酰半胱氨酸对 MK-801 诱导的小鼠神经退行性变的保护作用。
Mol Biol Rep. 2023 Dec;50(12):10287-10299. doi: 10.1007/s11033-023-08881-9. Epub 2023 Nov 16.
2
Cerebral venous congestion alters brain metabolite profiles, impairing cognitive function.脑静脉淤血改变了脑代谢物谱,损害了认知功能。
J Cereb Blood Flow Metab. 2023 Nov;43(11):1857-1872. doi: 10.1177/0271678X231182244. Epub 2023 Jun 13.
3
Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia.
近期关于氧化还原应激诱导的线粒体DNA变异、神经胶质细胞相互作用以及精神分裂症病理生理学中NMDA受体系统的报告。
Mol Neurobiol. 2022 Apr;59(4):2472-2496. doi: 10.1007/s12035-021-02703-4. Epub 2022 Jan 27.
4
Potential Novel Therapies for Neurodevelopmental Diseases Targeting Oxidative Stress.针对氧化应激的神经发育性疾病的潜在新型治疗方法。
Oxid Med Cell Longev. 2021 Jul 22;2021:6640206. doi: 10.1155/2021/6640206. eCollection 2021.
5
Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives.氧化应激相关机制在精神分裂症发病机制中的作用及新的治疗观点。
Oxid Med Cell Longev. 2021 Jan 23;2021:8881770. doi: 10.1155/2021/8881770. eCollection 2021.
6
N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons.N-乙酰半胱氨酸可预防奥氮平诱导的 mHypoA-59 下丘脑神经元氧化应激。
Sci Rep. 2020 Nov 5;10(1):19185. doi: 10.1038/s41598-020-75356-3.
7
Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate.首发精神病的早期治疗反应:谷胱甘肽和谷氨酸的 7-T 磁共振波谱研究。
Mol Psychiatry. 2020 Aug;25(8):1640-1650. doi: 10.1038/s41380-020-0704-x. Epub 2020 Mar 24.
8
Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials.补充N-乙酰半胱氨酸(NAC)对精神分裂症阳性和阴性症状量表的影响:随机对照试验的系统评价和荟萃分析
Eur J Clin Pharmacol. 2019 Mar;75(3):289-301. doi: 10.1007/s00228-018-2595-1. Epub 2018 Nov 16.
9
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.N-乙酰半胱氨酸对精神分裂症患者脑谷氨酸水平和静息灌注的影响。
Psychopharmacology (Berl). 2018 Oct;235(10):3045-3054. doi: 10.1007/s00213-018-4997-2. Epub 2018 Aug 23.
10
Role of Novel Dietary Supplement N-acetyl Cysteine in Treating Negative Symptoms in Schizophrenia: A 6-Month Follow-up Study.新型膳食补充剂N-乙酰半胱氨酸在治疗精神分裂症阴性症状中的作用:一项6个月的随访研究。
Indian J Psychol Med. 2018 Mar-Apr;40(2):139-142. doi: 10.4103/IJPSYM.IJPSYM_322_17.